Microglia is an active player in how glibenclamide improves stroke outcome

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 7, 2013, Pages 1138-1139

  Ortega, Francisco J ^a,b   Jolkkonen, Jukka ^b   Rodríguez, Manuel J ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLIBENCLAMIDE;

ASTROCYTE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL DAMAGE; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; ENDOPLASMIC RETICULUM; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; NOTE; OLIGODENDROGLIA; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRAUMATIC BRAIN INJURY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CENTRAL NERVOUS SYSTEM; HUMANS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 84880329458     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.72     Document Type: Note

References (10)

1. Simard JM, Woo SK, Schwartzbauer GT, Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: A focused review. J Cereb Blood Flow Metab 2012; 32: 1699-1717
2. Liu X, Wu J-Y, Zhou F, Sun X-L, Yao H-H, Yang Y et al. The regulation of rotenoneinduced inflammatory factor production by ATP-sensitive potassium channel expressed in BV-2 cells. Neurosci Lett 2006; 394: 131-135
3. Ortega FJ, Gimeno-Bayon J, Espinosa-Parrilla JF, Carrasco JL, Batlle M, Pugliese M et al. ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats. Exp Neurol 2012; 235: 282-296
4. Ortega FJ, Jolkkonen J, Mahy N, Rodriguez MJ. Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2013; 33: 356-364
5. Virgili N, Espinosa-Parrilla JF, Mancera P, Pastén-Zamorano A, Gimeno-Bayon J, Rodríguez MJ et al. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis. J Neuroinflammation 2011; 8: 149
6. Zhou F, Yao H-H, Wu J-Y, Ding J-H, Sun T, Hu G. Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation. J Cell Mol Med 2008; 12: 1559-1570
7. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L et al. Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke. Nat Med 2006; 12: 433-440
8. Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 2009; 40: 604-609
9. Chen M, Dong Y, Simard JM. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci 2003; 23: 8568-8577
10. Simard JM, Tsymbalyuk N, Tsymbalyuk O, Ivanova S, Yurovsky V, Gerzanich V. Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke 2010; 41: 531-537